Amazon has expanded access to its artificial intelligence-powered healthcare assistant, bringing the tool — known as Health AI — to its main website and mobile app as the technology giant accelerates its push into the digital healthcare sector.
The assistant was previously available only within the platform of One Medical, the primary care provider Amazon acquired in 2023 in a $3.9 billion deal that marked one of the company’s most significant moves into the healthcare industry.
By integrating Health AI into the broader Amazon ecosystem, the company is making the assistant accessible to millions more users, including people who are not subscribers to its Prime membership program and those who are not enrolled in One Medical’s healthcare services.
Register for Tekedia Mini-MBA edition 20 (June 8 – Sept 5, 2026).
Register for Tekedia AI in Business Masterclass.
Join Tekedia Capital Syndicate and co-invest in great global startups.
Register for Tekedia AI Lab.
The expansion follows Amazon’s strategy of embedding healthcare tools directly into consumer platforms that people already use regularly, potentially transforming routine health inquiries, appointment scheduling, and prescription management into services that can be accessed alongside everyday digital activities such as shopping and entertainment.
According to Amazon, Health AI can answer health-related questions, explain medical records, manage prescription renewals, and help users schedule appointments. The system can also guide symptoms and treatments and direct users to healthcare providers when necessary.
While the assistant can answer general health questions without access to personal data, Amazon designed the system to function as a personalized health companion if users choose to connect their medical information.
When granted access, the assistant can analyze laboratory results, diagnoses, and medication histories to provide tailored explanations and recommendations.
The integration relies on the nationwide Health Information Exchange system, which allows healthcare providers to securely share patient medical records across the United States. Through this network, Health AI can interpret a patient’s clinical data and generate explanations about conditions, test results, or potential medication interactions.
For instance, users might ask the system to explain cholesterol test results or seek advice on symptoms such as congestion, sore throat, or fatigue. If the AI determines that professional care may be required, it can connect the user to clinicians affiliated with One Medical.
For U.S. Prime members, Amazon is offering an additional telehealth incentive: up to five free direct-message consultations with a One Medical provider for more than 30 common conditions. These conditions include respiratory infections such as colds and flu, allergies, acid reflux, pink eye, urinary tract infections, erectile dysfunction, and certain dermatological issues, including anti-aging skincare and hair loss.
Users who are not Prime subscribers can still access One Medical services through Amazon’s pay-per-visit telehealth model.
The expansion denotes Amazon’s broader ambition to create an integrated healthcare ecosystem that combines artificial intelligence, telemedicine, pharmacy services, and data-driven health insights under one digital umbrella.
Over the past several years, the company has been steadily assembling pieces of that ecosystem, including online pharmacy operations and prescription delivery services.
By combining these assets with AI-driven health assistants, Amazon appears to be attempting to streamline parts of the healthcare experience that are often slow, confusing, or fragmented for patients. For example, many patients struggle to interpret lab results or understand medical terminology in clinical reports. AI assistants trained on medical knowledge can translate those documents into plain language explanations, potentially helping patients make more informed decisions about treatment or follow-up care.
Healthcare experts say tools like Health AI could also reduce pressure on overstretched medical systems by helping patients triage symptoms before seeking clinical attention. Yet the technology also raises serious questions about privacy, reliability, and the handling of sensitive health data.
Researchers and digital rights advocates have warned that AI-driven health assistants may collect large volumes of personal medical information, creating potential risks if the data is misused or inadequately protected. There is also growing concern that companies may use conversations with AI systems to improve and train their models.
Amazon said in a statement that it takes steps to prevent personal health information from being directly incorporated into AI training processes.
According to the company, Health AI models are trained on “abstracted patterns” rather than identifiable data. For instance, if numerous users ask about the interaction between certain medications, the system may learn from the general pattern of those queries while keeping patient identities private.
Amazon also said that conversations with Health AI take place within a system compliant with the U.S. Health Insurance Portability and Accountability Act, commonly known as HIPAA. The company added that interactions are protected through encryption and strict access controls. However, Amazon has not publicly detailed the technical architecture behind the encryption system or clarified which internal teams may have access to the stored data.
Privacy advocates say transparency about those safeguards will likely become increasingly important as AI systems begin handling sensitive medical information at scale.
The rollout of Health AI also reflects a broader shift across the artificial intelligence industry, where developers are increasingly tailoring generative AI tools for healthcare applications.
Earlier this year, OpenAI introduced a healthcare-focused version of its chatbot called ChatGPT Health, designed to answer medical questions and assist users with health-related inquiries. Shortly afterward, Anthropic unveiled its own medical-oriented AI system, Claude for Healthcare, highlighting intensifying competition among AI developers to capture a share of the healthcare technology market.
Healthcare is widely viewed as one of the most promising sectors for generative AI because of the enormous volumes of data generated by medical systems — from electronic health records to diagnostic imaging and laboratory results.
AI systems are already being tested to assist doctors with clinical documentation, summarize patient histories, analyze medical images, and help identify potential treatment options.
However, the use of AI in healthcare remains controversial. Regulators, medical professionals, and patient advocates are debating how much autonomy such systems should have and what safeguards are needed to prevent incorrect medical advice or misuse of sensitive information.
For Amazon, embedding Health AI into its main consumer platform may represent a calculated effort to normalize AI-assisted healthcare interactions. The company is attempting to integrate medical support into the daily digital routines of its users by positioning the assistant as a convenient tool for answering everyday health questions and facilitating telehealth visits.
If widely adopted, such systems could reshape how millions of people access basic medical guidance — potentially turning AI-powered assistants into a first point of contact for health concerns long before a patient visits a doctor.